Image-Guided Radiation Therapy for Renal Cell Carcinoma

2013 ◽  
pp. 689-697
Author(s):  
Ying Li ◽  
Gregory P. Swanson ◽  
Chul S. Ha
Author(s):  
M.C. Ranck ◽  
K.S. Corbin ◽  
D.W. Golden ◽  
S.L. Liauw ◽  
R.R. Weichselbaum ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-4 ◽  
Author(s):  
An Uche ◽  
Chad Sila ◽  
Tad Tanoura ◽  
James Yeh ◽  
Neil Bhowmick ◽  
...  

Cabozantinib represents an established vascular endothelial growth factor- (VEGF-) tyrosine kinase inhibitor (TKI) in the treatment paradigm of metastatic renal cell carcinoma (mRCC). Its activity in mRCC patients with brain metastases (BMs) has been largely underreported in prospective clinical trials. We present the unique case of a heavily pretreated mRCC patient with BMs who achieved a brain complete response to cabozantinib prior to receiving radiation therapy. We end with a literature review and discussion of the biologic rationale and growing evidence supporting the intracranial activity of cabozantinib.


Kidney Cancer ◽  
2015 ◽  
pp. 217-225
Author(s):  
Jonathan Verma ◽  
Anita Mahajan

2019 ◽  
Vol 12 (2) ◽  
pp. 381-388 ◽  
Author(s):  
Kyung Hwa Choi ◽  
Jeong Yong Jeon ◽  
Young-Eun Lee ◽  
Seung Won Kim ◽  
Sang Yong Kim ◽  
...  

1999 ◽  
pp. 599-600 ◽  
Author(s):  
FRANCIS J. McGOVERN ◽  
BRADFORD J. WOOD ◽  
S. NAHUM GOLDBERG ◽  
PETER R. MUELLER

Sign in / Sign up

Export Citation Format

Share Document